Elucidation of the anti-fibrotic diseases mechanism of chelerythrine by integrative approach of network pharmacology and experimental verification-Reference-Cited by-同舟云学术

Elucidation of the anti-fibrotic diseases mechanism of chelerythrine by integrative approach of network pharmacology and experimental verification

Published:2024-08-18 Issue: Volume: Page:1-7
ISSN:1478-6419
Container-title:Natural Product Research
language:en
Short-container-title:Natural Product Research

Author:

Han Wei¹²,Qian Gui-yun¹²,Wang Qin-rong³,Liu Jie¹,Zhang Yong-ping¹,Xu Jian¹,Li Tingting⁴,Li Zhe²⁵

Affiliation:

1. College of Pharmacy, Guizhou University of Traditional Chinese Medicine, Guiyang, P.R. China

2. Innovation Research and Development Center of Veterinary Traditional Chinese Medicine Preparations, Guizhou University of Traditional Chinese Medicine, Guiyang, P.R. China

3. Key Laboratory of Endemic and Ethnic Diseases, Ministry of Education, Guizhou Medical University, Guiyang, P.R. China

4. School of Medicine, Guangxi University of Science and Technology, Liuzhou, P.R. China

5. College of Basic Medicine, Guizhou University of Traditional Chinese Medicine, Guiyang, P.R. China

Funder

Key Laboratory of Endemic and Ethnic Diseases, Ministry of Education, Guizhou Medical University

National Natural Science Foundation of China

Guangxi Natural Science Foundation

Academic New Talent Project of Guizhou Provincial Department of science and Technology

High-level innovative talents in Guizhou Province

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/14786419.2024.2391071

Reference26 articles.

1. Chelerythrine ameliorates rheumatoid arthritis by modulating the AMPK/mTOR/ULK-1 signaling pathway

2. Rediscovery of Traditional Plant Medicine: An Underestimated Anticancer Drug of Chelerythrine

3. Factors Affecting the Evaluation of Collagen Deposition and Fibrosis In Vitro

4. Hepatic fibrosis 2022: Unmet needs and a blueprint for the future

5. N-(2-Aminophenyl)-benzamide Inhibitors of Class I HDAC Enzymes with Antiproliferative and Antifibrotic Activity